we have studied the deactivation of the in vivo actions of insulin and biosynthetic human proinsulin ( recombinant dna ) to stimulate the glucose disposal rate ( gdr ) and to inhibit hepatic glucose output ( hgo ) in man .
C0021641
insulin
C0033362
proinsulin